Biodelphis Therapeutics, an EPFL spin-off, couples a small molecule with an antibody to treat osteoporosis without acting on the whole body. The CHF 100,000 Tech Seed loan from FIT funds the studies that precede the first human trials.
- Announced on
- Round
- Loan
- Amount
- CHF 100,000
- Location
- Lausanne, canton of Vaud
- Sector
- Biotech & life sciences
Investors
- FIT Vaud (Innovaud) lead
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic